- •Foreword
- •Preface
- •Contents
- •Chapter 1
- •The Apparently Blind Infant
- •Introduction
- •Hereditary Retinal Disorders
- •Leber Congenital Amaurosis
- •Joubert Syndrome
- •Congenital Stationary Night Blindness
- •Achromatopsia
- •Congenital Optic Nerve Disorders
- •Cortical Visual Insufficiency
- •Causes of Cortical Visual Loss
- •Perinatal Hypoxia-Ischemia
- •Postnatal Hypoxia-Ischemia
- •Cerebral Malformations
- •Head Trauma
- •Twin Pregnancy
- •Metabolic and Neurodegenerative Conditions
- •Meningitis, Encephalitis, and Sepsis
- •Hydrocephalus, Ventricular Shunt Failure
- •Preictal, Ictal, or Postictal Phenomena
- •Associated Neurologic and Systemic Disorders
- •Characteristics of Visual Function
- •Neuro-Ophthalmologic Findings
- •Diagnostic and Prognostic Considerations
- •Role of Visual Attention
- •Neuroimaging Abnormalities and their Implications
- •Subcortical Visual Loss (Periventricular Leukomalacia)
- •Perceptual Difficulties
- •Dorsal and Ventral Stream Dysfunction
- •Pathophysiology
- •Intraventricular Hemorrhage
- •Hemianopic Visual Field Defects in Children
- •Delayed Visual Maturation
- •Blindsight
- •The Effect of Total Blindness on Circadian Regulation
- •Horizons
- •References
- •Chapter 2
- •Congenital Optic Disc Anomalies
- •Introduction
- •Optic Nerve Hypoplasia
- •Segmental Optic Nerve Hypoplasia
- •Excavated Optic Disc Anomalies
- •Morning Glory Disc Anomaly
- •Optic Disc Coloboma
- •Peripapillary Staphyloma
- •Megalopapilla
- •Optic Pit
- •Congenital Tilted Disc Syndrome
- •Optic Disc Dysplasia
- •Congenital Optic Disc Pigmentation
- •Aicardi Syndrome
- •Doubling of the Optic Disc
- •Optic Nerve Aplasia
- •Myelinated (Medullated) Nerve Fibers
- •The Albinotic Optic Disc
- •References
- •Chapter 3
- •The Swollen Optic Disc in Childhood
- •Introduction
- •Papilledema
- •Pathophysiology
- •Neuroimaging
- •Primary IIH in Children
- •Secondary IIH
- •IIH Secondary to Neurological Disease
- •IIH Secondary to Systemic Disease
- •Malnutrition
- •Severe Anemia
- •Addison Disease
- •Bone Marrow Transplantation
- •Renal Transplantation
- •Down Syndrome
- •Gliomatosis Cerebri
- •Systemic Lupus Erythematosis
- •Sleep Apnea
- •Postinfectious
- •Childhood IIH Associated with Exogenous Agents
- •Atypical IIH
- •Treatment of IIH in Children
- •Prognosis of IIH in Children
- •Optic Disc Swelling Secondary to Neurological Disease
- •Hydrocephalus
- •Neurofibromatosis
- •Spinal Cord Tumors
- •Subacute Sclerosing Panencephalitis
- •Optic Disc Swelling Secondary to Systemic Disease
- •Diabetic Papillopathy
- •Malignant Hypertension
- •Sarcoidosis
- •Leukemia
- •Cyanotic Congenital Heart Disease
- •Craniosynostosis Syndromes
- •Nonaccidental Trauma (Shaken Baby Syndrome)
- •Cysticercosis
- •Mucopolysaccharidosis
- •Infantile Malignant Osteopetrosis
- •Malaria
- •Paraneoplastic
- •Uveitis
- •Blau Syndrome
- •CINCA
- •Kawasaki Disease
- •Poststreptococal Uveitis
- •Intrinsic Optic Disc Tumors
- •Optic Disc Hemangioma
- •Tuberous Sclerosis
- •Optic Disc Glioma
- •Combined Hamartoma of the Retina and RPE
- •Retrobulbar Tumors
- •Optic Neuritis in Children
- •History and Physical Examination
- •Postinfectious Optic Neuritis
- •Acute Disseminated Encephalomyelitis
- •MS and Pediatric Optic Neuritis
- •Devic Disease (Neuromyelitis Optica)
- •Prognosis and Treatment
- •Course of Visual Loss and Visual Recovery
- •Systemic Prognosis
- •Systemic Evaluation of Pediatric Optic Neuritis
- •Treatment
- •Leber Idiopathic Stellate Neuroretinitis
- •Ischemic Optic Neuropathy
- •Autoimmune Optic Neuropathy
- •Pseudopapilledema
- •Optic Disc Drusen
- •Epidemiology
- •Ophthalmoscopic Appearance in Children
- •Distinguishing Buried Disc Drusen from Papilledema
- •Fluorescein Angiographic Appearance
- •Neuroimaging
- •Histopathology
- •Pathogenesis
- •Ocular Complications
- •Systemic Associations
- •Natural History and Prognosis
- •Systemic Disorders Associated with Pseudopapilledema
- •Down Syndrome
- •Alagille Syndrome
- •Kenny Syndrome
- •Leber Hereditary Neuroretinopathy
- •Mucopolysaccharidosis
- •Linear Sebaceous Nevus Syndrome
- •Orbital Hypotelorism
- •References
- •Chapter 4
- •Optic Atrophy in Children
- •Introduction
- •Epidemiology
- •Optic Atrophy Associated with Retinal Disease
- •Congenital Optic Atrophy Vs. Hypoplasia
- •Causes of Optic Atrophy in Children
- •Compressive/Infiltrative Intracranial Lesions
- •Optic Glioma
- •Craniopharyngioma
- •Noncompressive Causes of Optic Atrophy in Children with Brain Tumors
- •Postpapilledema Optic Atrophy
- •Paraneoplastic Syndromes
- •Radiation Optic Neuropathy
- •Hydrocephalus
- •Hereditary Optic Atrophy
- •Dominant Optic Atrophy (Kjer Type)
- •Leber Hereditary Optic Neuropathy
- •Recessive Optic Atrophy
- •X-Linked Optic Atrophy
- •Behr Syndrome
- •Wolfram Syndrome (DIDMOAD)
- •Toxic/Nutritional Optic Neuropathy
- •Neurodegenerative Disorders with Optic Atrophy
- •Krabbe’s Infantile Leukodystrophy
- •Canavan Disease (Spongiform Leukodystrophy)
- •PEHO Syndrome
- •Neonatal Leukodystrophy
- •Metachromatic Leukodystrophy
- •Pantothenate Kinase-Associated Neurodegeneration
- •Neuronal Ceroid Lipofuscinoses (Batten Disease)
- •Familial Dysautonomia (Riley–Day Syndrome)
- •Infantile Neuroaxonal Dystrophy
- •Organic Acidurias
- •Propionic Acidemia
- •Cobalamin C Deficiency with Methylmalonic Acidemia
- •Spinocerebellar Degenerations
- •Hereditary Polyneuropathies
- •Mucopolysaccharidoses
- •Optic Atrophy due to Hypoxia-Ischemia
- •Traumatic Optic Atrophy
- •Vigabatrin
- •Carboplatin
- •Summary of the General Approach to the Child with Optic Atrophy
- •References
- •Chapter 5
- •Transient, Unexplained, and Psychogenic Visual Loss in Children
- •Introduction
- •Transient Visual Loss
- •Migraine
- •Migraine Aura
- •Amaurosis Fugax as a Migraine Equivalent
- •Migraine Versus Retinal Vasospasm
- •Migraine Headache
- •Complicated Migraine
- •Pathophysiology
- •Genetics
- •Sequelae
- •Treatment
- •Epilepsy
- •Epileptiform Visual Symptoms with Seizure Aura
- •Ictal Cortical Blindness
- •Postictal Blindness
- •Distinguishing Epilepsy from Migraine
- •Vigabitrin-Associated Visual Field Loss
- •Posttraumatic Transient Cerebral Blindness
- •Cardiogenic Embolism
- •Nonmigrainous Cerebrovascular Disease
- •Transient Visual Obscurations Associated with Papilledema
- •Anomalous Optic Discs
- •Entoptic Images
- •Media Opacities
- •Retinal Circulation
- •Phosphenes
- •Uhthoff Symptom
- •Alice in Wonderland Syndrome
- •Charles Bonnet Syndrome
- •Lilliputian Hallucinations
- •Palinopsia
- •Peduncular Hallucinosis
- •Hypnagogic Hallucinations
- •Posterior Reversible Encephalopathy Syndrome
- •Neurodegenerative Disease
- •Multiple Sclerosis
- •Schizophrenia
- •Hallucinogenic Drug Use
- •Cannabinoid Use
- •Toxic and Nontoxic Drug Effects
- •Antimetabolites and Cancer Therapy
- •Digitalis
- •Erythropoietin
- •Atropine (Anticholinergic Drugs)
- •Carbon Monoxide
- •Summary of Clinical Approach to the Child with Transient Visual Disturbances
- •Unexplained Visual Loss in Children
- •Transient Amblyogenic Factors
- •Refractive Abnormalities
- •Cornea
- •Retina
- •Optic Nerve
- •Central Nervous System
- •Psychogenic Visual Loss in Children
- •Clinical Profile
- •Neuro-Ophthalmologic Findings
- •Group 1: The Visually Preoccupied Child
- •Group 2: Conversion Disorder
- •Group 3: Possible Factitious Disorder
- •Group 4: Psychogenic Visual Loss Superimposed on True Organic Disease
- •Interview with the Parents
- •Interview with the Child
- •When to Refer Children with Psychogenic Visual Loss for Psychiatric Treatment
- •Horizons
- •References
- •Chapter 6
- •Ocular Motor Nerve Palsies in Children
- •Introduction
- •Oculomotor Nerve Palsy
- •Clinical Anatomy
- •Nucleus
- •Fascicle
- •Clinical Features
- •Isolated Inferior Rectus Muscle Palsy
- •Isolated Inferior Oblique Muscle Palsy
- •Isolated Internal Ophthalmoplegia
- •Isolated Divisional Oculomotor Palsy
- •Oculomotor Synkinesis
- •Etiology
- •Congenital Third Nerve Palsy
- •Congenital Third Nerve Palsy with Cyclic Spasm
- •Traumatic Third Nerve Palsy
- •Meningitis
- •Ophthalmoplegic Migraine
- •Recurrent Isolated Third Nerve Palsy
- •Cryptogenic Third Nerve Palsy in Children
- •Vascular Third Nerve Palsy in Children
- •Postviral Third Nerve Palsy
- •Differential Diagnosis
- •Management
- •Amblyopia
- •Ocular Alignment
- •Ptosis
- •Trochlear Nerve Palsy
- •Clinical Anatomy
- •Clinical Features
- •Head Posture
- •Three-Step Test
- •Bilateral Trochlear Nerve Palsy
- •Etiology
- •Traumatic Trochlear Nerve Palsy
- •Congenital Trochlear Nerve Palsy
- •Large Vertical Fusional Vergence Amplitudes
- •Facial Asymmetry
- •Synostotic Plagiocephaly
- •Hydrocephalus
- •Idiopathic
- •Compressive Lesions
- •Rare Causes of Trochlear Nerve Palsy
- •Differential Diagnosis
- •Treatment
- •Abducens Nerve Palsy
- •Clinical Anatomy
- •Clinical Features
- •Causes of Sixth Nerve Palsy
- •Congenital Sixth Nerve Palsy
- •Traumatic Sixth Nerve Palsy
- •Benign Recurrent Sixth Nerve Palsy
- •Pontine Glioma
- •Elevated Intracranial Pressure
- •Infectious Sixth Nerve Palsy
- •Inflammatory Sixth Nerve Palsy
- •Rare Causes of Sixth Nerve Palsy
- •Differential Diagnosis
- •Duane Retraction Syndrome
- •Genetics
- •Other Clinical Features of Duane Syndrome
- •Upshoots and Downshoots
- •Y or l Pattern
- •Synergistic Divergence
- •Rare Variants
- •Systemic Associations
- •Etiology of Duane Syndrome
- •Classification of Duane Syndrome on the Basis of Range of Movement
- •Embryogenesis
- •Surgical Treatment of Duane Syndrome
- •Esotropia in Duane Syndrome
- •Duane Syndrome with Exotropia
- •Bilateral Duane Syndrome
- •Management of Sixth Nerve Palsy
- •Multiple Cranial Nerve Palsies in Children
- •Horizons
- •References
- •Chapter 7
- •Complex Ocular Motor Disorders in Children
- •Introduction
- •Strabismus in Children with Neurological Dysfunction
- •Visuovestibular Disorders
- •Neurologic Esotropia
- •Spasm of the Near Reflex
- •Exercise-Induced Diplopia
- •Neurologic Exotropia
- •Convergence Insufficiency
- •Skew Deviation
- •Horizontal Gaze Palsy in Children
- •Congenital Ocular Motor Apraxia
- •Vertical Gaze Palsies in Children
- •Downgaze Palsy in Children
- •Upgaze Palsy in Children
- •Diffuse Ophthalmoplegia in Children
- •Myasthenia Gravis
- •Transient Neonatal Myasthenia
- •Congenital Myasthenic Syndromes
- •Juvenile Myasthenia
- •Olivopontocerebellar Atrophy
- •Botulism
- •Bickerstaff Brainstem Encephalitis
- •Tick Paralysis
- •Wernicke Encephalopathy
- •Miscellaneous Causes of Ophthalmoplegia
- •Transient Ocular Motor Disturbances of Infancy
- •Transient Neonatal Strabismus
- •Transient Idiopathic Nystagmus
- •Tonic Downgaze
- •Tonic Upgaze
- •Neonatal Opsoclonus
- •Transient Vertical Strabismus in Infancy
- •Congenital Ptosis
- •Congenital Fibrosis Syndrome
- •Möbius Sequence
- •Monocular Elevation Deficiency, or “Double Elevator Palsy”
- •Brown Syndrome
- •Other Pathologic Synkineses
- •Internuclear Ophthalmoplegia
- •Cyclic, Periodic, or Aperiodic Disorders Affecting Ocular Structures
- •Ocular Neuromyotonia
- •Eye Movement Tics
- •Eyelid Abnormalities in Children
- •Congenital Ptosis
- •Excessive Blinking in Children
- •Hemifacial Spasm
- •Eyelid Retraction
- •Apraxia of Eyelid Opening
- •Pupillary Abnormalities
- •Congenital Bilateral Mydriasis
- •Accommodative Paresis
- •Adie Syndrome
- •Horner Syndrome
- •References
- •Chapter 8
- •Nystagmus in Children
- •Introduction
- •Infantile Nystagmus
- •Clinical Features
- •Onset of Infantile Nystagmus
- •Terminology
- •History and Physical Examination
- •Relevant History
- •Physical Examination
- •Hemispheric Visual Evoked Potentials
- •Immature Infantile Nystagmus Waveforms
- •Mature Infantile Nystagmus Waveforms
- •Fixation in Infantile Nystagmus
- •Smooth Pursuit System in Infantile Nystagmus
- •Vestibulo-ocular Reflex in Infantile Nystagmus
- •Saccadic System in Infantile Nystagmus
- •Suppression of Oscillopsia in Infantile Nystagmus
- •Albinism
- •Achiasmia
- •Isolated Foveal Hypoplasia
- •Congenital Retinal Dystrophies
- •Cone and Cone-Rod Dystrophies
- •Achromatopsia
- •Blue Cone Monochromatism
- •Leber Congenital Amaurosis
- •Alström Syndrome
- •Rod-Cone Dystrophies
- •Congenital Stationary Night Blindness
- •Medical Treatment
- •Optical Treatment
- •Surgical Treatment
- •Surgery to Improve Torticollis
- •Surgery to Improve Vision
- •Tenotomy with Reattachment
- •Four Muscle Recession
- •Artificial Divergence Surgery
- •When to Obtain Neuroimaging Studies in Children with Nystagmus
- •Treatment
- •Spasmus Nutans
- •Russell Diencephalic Syndrome of Infancy
- •Monocular Nystagmus
- •Nystagmus Associated with Infantile Esotropia
- •Torsional Nystagmus
- •Horizontal Nystagmus
- •Latent Nystagmus
- •Treatment of Manifest Latent Nystagmus
- •Nystagmus Blockage Syndrome
- •Treatment of Nystagmus Blockage Syndrome
- •Vertical Nystagmus
- •Upbeating Nystagmus in Infancy
- •Congenital Downbeat Nystagmus
- •Hereditary Vertical Nystagmus
- •Periodic Alternating Nystagmus
- •Seesaw Nystagmus
- •Congenital versus Acquired Seesaw Nystagmus
- •Saccadic Oscillations that Simulate Nystagmus
- •Convergence-Retraction Nystagmus
- •Opsoclonus and Ocular Flutter
- •Causes of Opsoclonus
- •Kinsbourne Encephalitis
- •Miscellaneous Causes
- •Pathophysiology
- •Voluntary Nystagmus
- •Ocular Bobbing
- •Neurological Nystagmus
- •Pelizaeus-Merzbacher Disease
- •Joubert Syndrome
- •Santavuori-Haltia Disease
- •Infantile Neuroaxonal Dystrophy
- •Down Syndrome
- •Hypothyroidism
- •Maple Syrup Urine Disease
- •Nutritional Nystagmus
- •Epileptic Nystagmus
- •Summary
- •References
- •Chapter 9
- •Torticollis and Head Oscillations
- •Introduction
- •Torticollis
- •Ocular Torticollis
- •Head Tilts
- •Incomitant Strabismus
- •Synostotic Plagiocephaly
- •Spasmus Nutans
- •Infantile Nystagmus
- •Benign Paroxysmal Torticollis of Infancy
- •Dissociated Vertical Divergence
- •Ocular Tilt Reaction
- •Photophobia, Epiphora, and Torticollis
- •Down Syndrome
- •Spasmodic Torticollis
- •Head Turns
- •Seizures
- •Cortical Visual Insufficiency
- •Congenital Ocular Motor Apraxia
- •Vertical Head Positions
- •Refractive Causes of Torticollis
- •Neuromuscular Causes of Torticollis
- •Congenital Muscular Torticollis
- •Systemic Causes of Torticollis
- •Head Oscillations
- •Head Nodding with Nystagmus
- •Spasmus Nutans
- •Infantile Nystagmus
- •Head Nodding without Nystagmus
- •Bobble-Headed Doll Syndrome
- •Cerebellar Disease
- •Benign Essential Tremor
- •Paroxysmal Dystonic Head Tremor
- •Autism
- •Infantile Spasms
- •Congenital Ocular Motor Apraxia
- •Opsoclonus/Myoclonus
- •Visual Disorders
- •Blindness
- •Intermittent Esotropia
- •Otological Abnormalities
- •Labyrinthine Fistula
- •Systemic Disorders
- •Aortic Regurgitation
- •Endocrine and Metabolic Disturbances
- •Nasopharyngeal Disorders
- •Organic Acidurias
- •References
- •Chapter 10
- •Introduction
- •Neuronal Disease
- •Neuronal Ceroid Lipofuscinosis
- •Infantile NCL (Santavuori-Haltia Disease)
- •Late Infantile (Jansky–Bielschowsky Disease)
- •Juvenile NCL (Batten Disease)
- •Lysosomal Diseases
- •Gangliosidoses
- •GM2 Type I (Tay–Sachs Disease)
- •GM2 Type II (Sandhoff Disease)
- •GM2 Type III
- •Niemann–Pick Disease
- •Gaucher Disease
- •Mucopolysaccharidoses
- •MPS1H (Hurler Syndrome)
- •MPS1S (Scheie Syndrome)
- •MPS2 (Hunter Syndrome)
- •MPS3 (Sanfilippo Syndrome)
- •MPS4 (Morquio Syndrome)
- •MPS6 (Maroteaux–Lamy Syndrome)
- •MPS7 (Sls Syndrome)
- •Sialidosis
- •Subacute Sclerosing Panencephalitis
- •White Matter Disorders
- •Metachromatic Leukodystrophy
- •Krabbe Disease
- •Pelizaeus–Merzbacher Disease
- •Cockayne Syndrome
- •Alexander Disease
- •Sjögren–Larsson Syndrome
- •Cerebrotendinous Xanthomatosis
- •Peroxisomal Disorders
- •Zellweger Syndrome
- •Adrenoleukodystrophy
- •Basal Ganglia Disease
- •Wilson Disease
- •Maple Syrup Urine Disease
- •Homocystinuria
- •Abetalipoproteinemia
- •Mitochondrial Encephalomyelopathies
- •Myoclonic Epilepsy and Ragged Red Fibers (MERRF)
- •Mitochondrial Depletion Syndrome
- •Congenital Disorders of Glycosylation
- •Horizons
- •References
- •Chapter 11
- •Introduction
- •The Phakomatoses
- •Neurofibromatosis (NF1)
- •Neurofibromatosis 2 (NF2)
- •Tuberous Sclerosis
- •Sturge–Weber Syndrome
- •von Hippel–Lindau Disease
- •Ataxia Telangiectasia
- •Linear Nevus Sebaceous Syndrome
- •Klippel–Trenauney–Weber Syndrome
- •Brain Tumors
- •Suprasellar Tumors
- •Pituitary Adenomas
- •Rathke Cleft Cysts
- •Arachnoid Cysts
- •Cavernous Sinus Lesions
- •Hemispheric Tumors
- •Hemispheric Astrocytomas
- •Gangliogliomas and Ganglioneuromas
- •Supratentorial Ependymomas
- •Primitive Neuroectodermal Tumors
- •Posterior Fossa Tumors
- •Medulloblastoma
- •Cerebellar Astrocytoma
- •Ependymoma
- •Brainstem Tumors
- •Tumors of the Pineal Region
- •Meningiomas
- •Epidermoids and Dermoids
- •Gliomatosis Cerebri
- •Metastasis
- •Hydrocephalus
- •Hydrocephalus due to CSF Overproduction
- •Noncommunicating Hydrocephalus
- •Communicating Hydrocephalus
- •Aqueductal Stenosis
- •Tumors
- •Intracranial Hemorrhage
- •Intracranial Infections
- •Chiari Malformations
- •Chiari I
- •Chiari II
- •Chiari III
- •The Dandy–Walker Malformation
- •Congenital, Genetic, and Sporadic Disorders
- •Clinical Features of Hydrocephalus
- •Ocular Motility Disorders in Hydrocephalus
- •Dorsal Midbrain Syndrome
- •Visual Loss in Hydrocephalus
- •Effects and Complications of Treatment
- •Vascular Lesions
- •AVMs
- •Clinical Features of AVMs in Children
- •Natural History
- •Treatment
- •Cavernous Angiomas
- •Intracranial Aneurysms
- •Isolated Venous Ectasia
- •Craniocervical Arterial Dissection
- •Strokes in Children
- •Cerebral Venous Thrombosis
- •Cerebral Dysgenesis and Intracranial Malformations
- •Destructive Brain Lesions
- •Porencephaly
- •Hydranencephaly
- •Encephalomalacia
- •Colpocephaly
- •Malformations Due to Abnormal Stem Cell Proliferation or Apoptosis
- •Schizencephaly
- •Hemimegalencephaly
- •Lissencephaly
- •Gray Matter Heterotopia
- •Malformations Secondary to Abnormal Cortical Organization and Late Migration
- •Polymicrogyria
- •Holoprosencephaly
- •Absence of the Septum Pellucidum
- •Hypoplasia, Agenesis, or Partial Agenesis of the Corpus Callosum
- •Focal Cortical Dysplasia
- •Anomalies of the Hypothalamic–Pituitary Axis
- •Posterior Pituitary Ectopia
- •Empty Sella Syndrome
- •Encephaloceles
- •Transsphenoidal Encephalocele
- •Orbital Encephalocele
- •Occipital Encephalocele
- •Cerebellar Malformations
- •Molar Tooth Malformation
- •Rhombencephalosynapsis
- •Lhermitte–Duclos Disease
- •Miscellaneous
- •Congenital Corneal Anesthesia
- •Reversible Posterior Leukoencephalopathy
- •Cerebroretinal Vasculopathies
- •Syndromes with Neuro-Ophthalmologic Overlap
- •Proteus Syndrome
- •PHACE Syndrome
- •Encephalocraniocutaneous Lipomatosis
- •References
- •Index
482 |
10 Neuro-Ophthalmologic Manifestations of Neurodegenerative Disease in Childhood |
|
|
most patients suffer from photophobia and subnormal visual acuity. A crystalline maculopathy, in which crystalline dots are scattered throughout the perifovea within the inner retinal layers, develops in early childhood. These crystals should be specifically sought in the child who presents with icthyosis, as they are present whenever the enzyme deficiency is found. Optical coherence tomography (OCT) shows focal hyperreflectivities in the perifoveal ganglion cell and inner plexiform layers, together with a cystic foveal atrophy that is not visible ophthalmoscopically.113 MR imaging shows an arrest in myelination, signal abnormalities involving periventricular white matter, and mild ventricular enlargement.351
Cerebrotendinous Xanthomatosis
Cerebrotendinous xanthomatosis is a rare autosomal lipid storage disease resulting from deficiency of the mitochondrial enzyme sterol 27-hydroxylase, resulting in a reduced production of cholic acid and particularly chenodeoxycholic acid, and leading to accumulation of cholestanol and cholesterol in many tissues.330 Cerebrotendinous xanthomatosis is an important form of neurodegeneration that should be suspected in children who have chronic diarrhea. These children have bilateral cataracts, which develop after the first few years of life, and are therefore not accompanied by nystagmus.73 Over time, these children suffer mental deterioration, pyramidal tract dysfunction, and cerebellar ataxia.330 They eventually develop a neurologic picture that resembles multiple sclerosis. Cerebral atrophy and deep cerebellar white matter lesions are found on MR imaging.32,155 In addition to developing bilateral cataracts, some patients show clinical signs of optic neuropathy.73 Chronic elevation of bile acids and cholestanol produce these neurologic abnormalities. It is critical to look for cataracts in the child with chronic diarrhea, because identification and treatment of this syndrome can prevent these neurologic complications. Early treatment with chenodeoxycholic acid stabilizes the condition.330
Peroxisomal Disorders
Peroxisomes are subcellular organelles that were first recognized in 1954 in the proximal tubule of the kidney. They are found in all eukaryotic species and in almost every cell. The name was chosen because these organelles produce and reduce hydrogen peroxide. They also contain enzymes needed for the oxidation of amino and dicarboxylic acids. In this process, H2O2 is formed and then detoxified by catalase, another peroxisomal enzyme.93,245 In 1973, Goldfischer129 discovered that peroxisomes were absent in liver and renal tubular
epithelial cells of patients with Zellweger syndrome. Various peroxisomal functions were found to be absent. A specific biomarker for screening patients was first identified in 1984,226 and the first gene defect was identified in 1992.285 Thus, the major clinical syndromes attributable to peroxisomal biogenesis disorders (Zellweger syndrome, neonatal adrenoleukodystrophy, infantile Refsum disease, and rhizomelic chondrodysplasia punctata) were all described before the biochemical and molecular mechanisms of peroxisomal dysfunction were understood.296
Inherited diseases of peroxisomes are divided into the peroxisomal biogenesis disorders, in which a mutation in one or more of the 12 peroxisomal assembly genes (PEX genes) results in a virtual absence of peroxisomes and a generalized loss in all peroxisomal function (e.g., the cerebrohepatorenal [Zellweger] syndrome, the infantile form of Refsum disease, the neonatal form of ALD, the rhizomelic type of chondrodysplasia punctata, and hyper-pipecolic acidemia), and those in which only a single peroxisomal function is impaired (e.g., X-linked adrenoleukodystrophy [ALD], the adult form of Refsum disease, and pseudorhizomelic chondrodysplasia).110,296,342
Abnormal retinal pigmentation occurs in Zellweger syndrome, neonatal ALD, hyper-pipecolic acidemia, and infantile Refsum disease. These children may have abnormal ERGs early in the course of the disease. Optic disc pallor has been reported in Zellweger syndrome, neonatal ALD, and hyperpipecolic acidemia.48,250
MR imaging studies in children with peroxisomal disorders have shown the following general abnormalities: (1) neuronal migrational disturbances in combination with hypomyelination, dysmyelination, or demyelination; (2) symmetrical demyelination of the posterior limb of the internal capsule, cerebellar white matter, and brainstem tracts with a variable affection of the cerebral hemispheres; and (3) symmetrical demyelination – exhibiting two zones: the first starting in the occipital area and spreading outward and forward, and the second involving the brainstem tracts. Biochemical studies performed on blood and urine are used to screen for the perioxisomal biogenesis disorders.296 DNA testing is possible for all of the disorders but is more challenging for Zellweger syndrome, which can be associated with 12 different PBX genes.296
Current treatment is mainly supportive, consisting of treating seizures, providing hearing aids, treating ocular disorders, and addressing other developmental needs. However, some therapeutic interventions have been successful in these patients. A diet low in phytanic acid has been successful in the treatment of adult Refsum disease. Oral bile acid administration has improved hepatobiiloary function in some infants with Zellweger syndrome. Newer experimental therapies directed at peroxisomal proliferation hold promise for more directed therapy.212,344
Peroxisomal Disorders |
483 |
|
|
Zellweger Syndrome
Zellweger hepatorenal syndrome is an autosomal recessive disease characterized by unique facies, failure to thrive, and visual impairment. The characteristic craniofacial features include a high forehead, hypoplastic supraorbital ridges, epicanthal folds, midface hypoplasia, and a large anterior fontanel.296 Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. There is absence of neonatal and deep tendon reflexes and little spontaneous movement.296 The eyes may demonstrate corneal clouding, cataracts, glaucoma, optic atrophy, and retinal anomalies, with extinguished ERG waveforms. Homozygotes also have characteristic lens abnormalities consisting of a dense cortex producing a cortical-nuclear interface that is visible at the slit lamp through a dilated pupil. Hittner et al153 have shown that the heterozygous parents of four infants with Zellweger syndrome had lens changes consisting of curvilinear condensations in the cortical region in the same location as the lens changes in the homozygous state. The liver is enlarged, and there are renal cysts. Bone stippling is seen at the patella and in other bones in about 50% of patients.296
Although most children die within the first year of life, a later-onset form is recognized in which there is some degree of psychomotor development, with development of head control, independent walking, and speech.296 These patients tend to have sensorineural hearing loss and retinitis pigmentosa, leading to the initial diagnosis of Usher syndrome or even Leber congenital amaurosis.296 The characteristic neuronal migration abnormalities are easily demonstrated by MR imaging.328 These include periventricular neuronal heterotopias, pachygyria, and polymicrogyria.347
In some children, a leukodystrophy develops, with degeneration of myelin in the CNS, loss of acquired skills, and development of spasticity.296 The gross pathologic abnormalities relate to neuronal migration abnormalities and polymicrogyri. Microscopically, there is evidence of gliosis and accumulation of lipids; however, unlike storage diseases, the lipid droplets in Zellweger syndrome are in the astrocytic cytoplasm rather than in macrophages.3 The severe lack of myelin noted histologically in the brains of these infants may be due to a combination of disturbed myelination and accelerated demyelination.4 The combination of neuronal and white matter disease is reflected in retinal ganglion cell abnormality and optic atrophy.
Zellweger syndrome is caused by mutations in the PXE complementation genes, with 12 genes known to cause variants of the condition.296 Defects in the PXE gene impair peroxisome assembly and multiple metabolic pathways confined to this organelle, providing the biochemical bases of the peroxisome biogenesis disorders.296 Zellweger cerebrohepatorenal syndrome is a severe form of diffuse peroxisomal deficiency.
Initially, the syndrome was attributed to the absence of or a decrease in the number of peroxisomes; however, peroxisomal membrane ghosts have now been identified in cells, indicating that Zellweger syndrome and other conditions like it may in fact be due to peroxisomal assembly abnormalities.274 Plasma levels of VLCFAs, pipecolic acid, phytanic acid, and bile acid intermediates are all elevated in this syndrome.
Adrenoleukodystrophy
Adrenoleukodystrophy (ALD) is an X-linked disorder with a wide spectrum of phenotypes, varying from the rapidly progressive, childhood-onset, predominantly cerebral form to the more slowly evolving subtypes characterized by adrenomyeloneuropathy or Addison disease.221 The common pathophysiological feature in all forms is the accumulation of C26:0 and C24:0 VLCFA in the CNS and other tissues owing to their impaired degradation as a consequence of perixosomal dysfunction.286 The gene for ALD has been mapped to Xq28.214 It encodes for a peroxisomal membrane component termed the ALD protein, which belongs to the class of adenosine triphosphate-binding cassette proteins.150 The deficiency of a single peroxisomal function in X-linked ALD differs from neonatal ALD, in which there is impairment of multiple peroxisomal functions, including deficiencies in very long chain fatty acid (VLCFA) oxidation by phytanic acid oxidase and plasmalogen synthesizing enzymes.277
X-linked ALD presents at an average age of 7 years. Initial manifestations include increased skin pigmentation, decreased school performance, and “dementia-type” changes in memory and emotional expression. Motor disturbances may be prominent, with a stiff-legged spastic gait. Visual disturbances are common and, occasionally, they occur early. Homonymous hemianopia,275 visual agnosia, decreased visual acuity, strabismus, selective reading dysfunction, and cerebral blindness have all been reported. Optic atrophy eventually develops.184,191,312,355 The childhood form may manifest with emotional lability and hyperactivity, leading to the diagnosis of attention-deficit hyperactivity disorder.105,224,299 Cognitive decline, poor school performance, and visual loss typically follow. Rarely, visual loss can be the presenting symptom of the disease. Other neurological deficits include hearing loss, progressive ataxia, and spastic quadriparesis. Children may have skin hyperpigmentation due to adrenal dysfunction and adrenal deficiency can be lethal. Hypoadrenalism,158 and hypogonadism105 may also complicate the clinical course.230 The disease is fatal if untreated.192
Infants with ALD (neonatal form) have severe hypotonia and seizures at birth, and later they exhibit growth and mental retardation. Other neurological features include macrocephaly, large fontanels, nystagmus, optic atrophy, pigmentary retinopathy, and abnormal vision and hearing. Most children die
484 |
10 Neuro-Ophthalmologic Manifestations of Neurodegenerative Disease in Childhood |
|
|
before 5 years of age. A few have survived until age 10. Other phenotypes include the rapidly progressive childhood form, the adolescent form, and the adult cerebral forms (adrenomyelopathy, which presents as slowly progressive paraparesis in adults, and Addison disease without neurologic manifestations).223 These phenotypes are frequently misdiagnosed, respectively, as attention-deficit hyperactivity disorder, multiple sclerosis, or idiopathic Addison disease. About 50% of female carriers develop a spastic paraparesis secondary to myelopathic changes similar to adrenomyeloneuropathy, often leading to the misdiagnosis of multiple sclerosis.
The biochemical hallmark of ALD is excess VLCFA, which can be measured in cultured skin fibroblasts, white cells, red blood phospholipids, or total plasma lipids. The concentration of C26:0 is elevated to approximately five times normal. Assays of long chain fatty acids in plasma, cultured chorion villus cells and amniocytes, and mutation analysis permit presymptomatic and prenatal diagnosis, as well as carrier identification. The timely use of these assays is essential for genetic counseling and therapy. Early diagnosis and treatment can prevent overt Addison’s disease and significantly reduce the frequency of the severe childhood cerebral phenotype. A promising new method for mass newborn screening has been developed. When implemented, it should have a profound effect on the diagnosis and management of X-linked ALD. Studies of choroinic villus sampling or amniocentesis now permit accurate prenatal identification of affected male fetuses. The finding of normal cognitive function in neurologically and radiologically normal boys with X-linked adrenoleukodystrophy suggests that prevention and timely institution of therapy can potentially preserve cognitive function.71 The plasma VLCFA assay is the recommended diagnostic procedure in males.222 Plasma VLCFA levels are increased on the day of birth.
Electrophysiological findings in two cases of neonatal ALD were reported by Verma et al333 One child was examined at age 1 year and the other at age 3½ years. Neither child demonstrated visual following responses, and both had severe seizures and long-tract signs. Both had nonrecordable or extremely diminished ERG responses and no consistent, identifiable positivity in VEP responses except for the right eye of the 1-year-old child, which showed a delayed positive wave with a mean latency of 137 ms. Ophthalmological examination of the younger patient showed normal media, normally reactive pupils, full extraocular movements, intermittent fine jerk nystagmus on horizontal gaze, and unremarkable fundi other than mild temporal pallor in each eye. The older child had sluggishly reactive pupils, pendular nystagmus, clear media, bilateral optic atrophy, and retinitis pigmentosa, suggesting a degeneration of photoreceptors and an accumulation of lipids in the ganglion cells.
Battaglia et al24 have studied the EEG, ERG, and flash VEP in 14 boys with X-linked ALD and in two siblings of
affected boys. These siblings had adrenocortical deficiency but were neurologically normal. All 14 affected boys had EEG abnormalities characterized by irregular, large-amplitude, slow activity. Similar EEG findings were seen in the two siblings of affected patients. The ERG was normal in all cases. The VEP was abnormal in four of 12 cases. The recording deteriorated over a short time frame in two cases and was low or unrecordable when first measured in two others. The VEPs in two siblings were normal.24 Detection of the carrier state of X-linked ALD by VEP has been reported.217
Neuroimaging studies are normal prior to the onset of symptoms.71 X-linked ALD classically involves the occipital white matter bilaterally. Areas of active demyelination may show intense contrast enhancement at the periphery of the lesions. These lesions are usually symmetric and may affect the posterior occipital region most severely. White matter lesions in the occipital region also characteristically involve the splenium of the corpus callosum early on. Occipital U fibers are relatively spared (Fig. 10.11). With time, the lesions extend forward to involve the lateral and medial geniculate bodies, the thalamus, and posterior limb of the internal capsule bilaterally. Cerebellar and brainstem white matter are relatively spared. Lesions are usually symmetric and may affect the posterior occipital region most severely, with the anterioroccipitalregionaffectedtoalesserextent.328 Pathologically disordered neuronal migration, including pachygyria and polymicrogyria, is the most striking abnormality.342
Fig. 10.11 Adrenoleukodystrophy. This T2-weighted MR image shows symmetrical hyperintense hemispheric lesions primarily involving occipital white matter (arrow)
